How a Biogen drug set the stage for a new biotech targeting ALS
Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke ...
unite4 小时
The Pace of AI: The Next Phase in the Future of Innovation
Since the emergence of ChatGPT, the world has entered an AI boom cycle. But, what most people don’t realize is that AI isn’t ...